Inherited retinal degenerations

International Ophthalmology Clinics

Volumn 50, Issue 4, 2010, Pages 45-56

  Fasiuddin, Airaj ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEST VITELLIFORM DYSTROPHY; CLINICAL FEATURE; COLOR BLINDNESS; ELECTRORETINOGRAM; GENETIC ASSOCIATION; HUMAN; INHERITANCE; LEBER CONGENITAL AMAUROSIS; NIGHT BLINDNESS; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA MACULA DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; STARGARDT DISEASE;

CHILD; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RETINAL DEGENERATION; RETINAL PIGMENT EPITHELIUM;

EID: 77958451214     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181f1287b     Document Type: Review

References (38)

1. Gouras P. Electroretinography: some basic principles. Invest Ophthalmol. 1970;9: 557-569.
2. Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field electroretinography (2008 update). Doc Ophthalmol. 2009;118:69-77.
3. Berson EL. Retinitis pigmentosa. The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 1993;34:1659-1676.
4. Franceschetti A, Dieterlé P. Importance diagnostique et prognostique de l'électro-rétinogramme (ERG), dans les dégénérescences tapéto-rétiniennes avec rétrécissement du champ visuel et héméralopie. Confin Neurol. 1954;14:184-186.
5. Carr R. Congenital stationary night blindness. Trans Am Ophthalmol Soc. 1974;72: 448-487.
6. Miyake Y, Yagasaki K, Horiguchi M, et al. Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol. 1986;104: 1013-1020.
7. Thiadens AA, Slingerland NW, Roosing S, et al. Genetic etiology and clinical consequences of complete and incomplete achromatopsia. Ophthalmology. 2009;116: 1984-1989.
8. Weleber RG, Carr RE, Murphey WH, et al. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol. 1993; 111:1531-1542.
9. Brown M, Marmor MF, Vaegan A. ISCEV Standard for Clinical Electro-oculography (EOG) 2006. Doc Ophthalmol. 2006;113:205-212.
10. Odom JV, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol. 2010;120:111-119.
11. Khani SC, Fasiuddin A. Generalized Inherited Retinal Dystrophies. In: Reynolds JD, Olitsky S, eds. Pediatric Retina. Springer-Verlag Berlin Heidelberg; 2010.
12. OMIM-Online Mendelian Inheritance in Man [database online] Baltimore, Maryland: Johns Hopkins University; 2010. Updated May 10, 2010.
13. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111: 761-772. (Pubitemid 23170587)
14. Fishman GA, Gilbert LD, Fiscella RG, et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol. 1989;107:1445-1452.
15. Chader GJ, Weiland J, Humayun MS. Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis. Prog Brain Res. 2009;175:317-332.
16. Leber T, Über retinitis pigmentosa und angeborene amaurose. Graefes Arch Clin Exp Ophthalmol. 1869;15:1-25.
17. Murayama K, Adachi-Usami E. Bilateral macular colobomas in Leber's congenital amaurosis. Doc Ophthalmol. 1989;72:181-188.
18. Wagner RS, Caputo AR, Nelson LB, et al. High hyperopia in Leber's congenital amaurosis. Arch Ophthalmol. 1985;103:1507-1509.
19. Jan JE, Good WV, Freeman RD, et al. Eye-poking. Dev med Child Neurol. 1994;36: 321-325.
20. Den Hollander AI, Roepman R, Koenekoop R, et al. Leber congenital amaurosis: genes, proteins and disease mechanisms. Progress Retinal Eye Res. 2008;27:391-419.
21. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
22. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240-2248.
23. Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Human Gene Therapy. 2008; 19:979-990.
24. Cideciyan AV, Hauswirth WW, Aleman TS, et al. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther. 2009;20:999-1004.
25. Price MJ, Thompson HS, Judisch GF, et al. Pupillary constriction to darkness. Br J Ophthalmol. 1985;69:205-211.
26. Flynn JT, Kazarian E, Barricks M. Paradoxical pupil in congenital achromatopsia. Int Ophthalmol. 1981;3:91-96.
27. Michaelides M, Hunt DM, Moore AT. The cone dysfunction syndromes. Br J Ophthalmol. 2004;88:291-297.
28. Park WL, Sunness JS. Red contact lenses for alleviation of photophobia in patients with cone disorders. Am J Ophthalmol. 2004;137:774-775.
29. Genead MA, Fishman GA, Stone EM, et al. The natural history of Stargardt disease with specific sequence mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci. 2009; 50:5867-5871.
30. Von Ruckmann A, Fitzke FW, Bird AC. In vivo autofluorescence in macular dystrophies. Arch Ophthalmol. 1997;115:609-615.
31. Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50:3953-3959.
32. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525-534.
33. Cideciyan AV, Swider M, Aleman TS, et al. ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet. 2009;18:931-941.
34. Querques G, Zerbib J, Santacroce R, et al. Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene. Mol Vis. 2009;15:2960-2972.
35. Vedanthan V, Ramasamy K. Optical coherence tomography in Best's disease: an observational case report. Am J Ophthalmol. 2005;139:351-353.
36. Andrade RE, Farah ME, Costa RA. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Best's disease. Am J Ophthalmol. 2003;136: 1179-1181.
37. Viola F, Villani E, Mapelli C, et al. Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy: observation versus photodynamic therapy. J Pediatr Ophthalmol Strabismus. 2010;47:121-122.
38. Rishi E, Rishi P, Mahajan S. Intravitreal bevacizumab for choroidal neovascular membrane with Best's vitelliform dystrophy. Indian J Ophthalmol. 2010;58:160-162.